首页> 美国卫生研究院文献>other >Quantitative Glycomic Analysis by Mass-Defect-Based Dimethyl Pyrimidinyl Ornithine (DiPyrO) Tags and High-Resolution Mass Spectrometry
【2h】

Quantitative Glycomic Analysis by Mass-Defect-Based Dimethyl Pyrimidinyl Ornithine (DiPyrO) Tags and High-Resolution Mass Spectrometry

机译:基于质量缺陷的二甲基嘧啶基鸟氨酸(DiPyrO)标签和高分辨率质谱定量糖分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently developed a novel amine-reactive mass-defect-based chemical tag, dimethyl pyrimidinyl ornithine (DiPyrO), for quantitative proteomic analysis at the MS1 level. In this work, we further extend the application of the DiPyrO tag, which provides amine group reactivity, optical detection capability, and improved electrospray sensitivity, to quantify N-linked glycans enzymatically released from glycoproteins in the glycosylamine form. Duplex DiPyrO tags that differ in mass by 45.3 mDa were used to label the glycosylamine moieties of freshly released N-glycosylamines from glycoprotein standards and human serum proteins. We demonstrate that both MALDI-LTQ-Orbitrap and nano-HILIC LC/MS/MS Fusion Lumos Orbitrap platforms are capable of resolving the singly or multiply charged N-glycans labeled with mass-defect DiPyrO tags. Dynamic range of quantification, based on MS1 peak intensities, was evaluated across 2 orders of magnitude. With optimized N-glycan release conditions, glycosylamine labeling conditions, and MS acquisition parameters, the N-glycan profiles and abundances in human serum proteins of cancer patients before and after chemotherapy were compared. Moreover, this study also opens a door for using well-developed amine-reactive tags for relative quantification of glycans, which could be widely applied.
机译:我们最近开发了一种新型的基于胺反应的基于质量缺陷的化学标签,二甲基嘧啶基鸟氨酸(DiPyrO),用于在MS 1 级别进行定量蛋白质组学分析。在这项工作中,我们进一步扩展了DiPyrO标签的应用,该标签可提供胺基反应性,光学检测功能和改进的电喷雾灵敏度,以定量从糖基胺形式的糖蛋白中酶促释放的N-连接的聚糖。质量相差45.3 mDa的双链DiPyrO标签用于标记糖蛋白标准品和人血清蛋白中新鲜释放的N-糖胺的糖胺部分。我们证明,MALDI-LTQ-Orbitrap和纳米-HILIC LC / MS / MS Fusion Lumos Orbitrap平台均能够解决带有质量缺陷DiPyrO标签的单电荷或多电荷N-聚糖。基于MS 1 峰强度的定量动态范围跨两个数量级进行了评估。通过优化的N-聚糖释放条件,糖胺标记条件和MS采集参数,比较了癌症患者化疗前后人血清蛋白中的N-聚糖谱和丰度。此外,这项研究还为使用发达的胺反应标签对聚糖进行相对定量打开了大门,这可以被广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号